Imidazolylchromanones containing non-benzylic oxime ethers: Synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii

被引:31
作者
Babazadeh-Qazijahani, Mojtaba [1 ]
Badali, Hamid [2 ]
Irannejad, Hamid [3 ,4 ]
Afsarian, Mohammad Hosein [2 ]
Emami, Saeed [3 ,4 ]
机构
[1] Mazandaran Univ Med Sci, Fac Pharm, Student Res Comm, Sari, Iran
[2] Mazandaran Univ Med Sci, Fac Med, Dept Med Mycol & Parasitol, Invas Fungi Res Ctr, Sari, Iran
[3] Mazandaran Univ Med Sci, Fac Pharm, Dept Med Chem, Sari, Iran
[4] Mazandaran Univ Med Sci, Fac Pharm, Pharmaceut Sci Res Ctr, Sari, Iran
关键词
Antifungal activity; Azole antifungals; Cryptococcus; Chroman-4-one; Imidazole; Lanosterol; 14; alpha-demethylase; SUSCEPTIBILITY;
D O I
10.1016/j.ejmech.2014.02.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of imidazolylchromanone oximes containing phenoxyethyl ether moiety, as found in omoconazole, were synthesized and evaluated against yeasts (Candida albicans and Cryptococcus gattii) and filamentous fungi (Aspergillus fumigatus and Exophiala dermatitidis). Although the title compounds showed marginal activity against filamentous fungi but all of them exhibited potent activity against C gattii (MIC values <= 4 mu g/mL). Among them, (3-chlorophenoxy)ethyl analog 7c with MIC value of 0.5 mu g/mL was the most potent compound. Further molecular docking studies provided a better insight into the binding of designed compounds within the homology modeled active site of CnCYP51 (Cryptococcus CYP51-14 alpha-demethylase). (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:264 / 273
页数:10
相关论文
共 23 条
[1]  
[Anonymous], 2008, APPROVED STANDARD M3
[2]  
[Anonymous], 2008, Approved standard M27-A. A National Committee for Clinical Laboratory Standards
[3]   The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling [J].
Arnold, K ;
Bordoli, L ;
Kopp, J ;
Schwede, T .
BIOINFORMATICS, 2006, 22 (02) :195-201
[4]   Optimization of 3-(phenylthio)quinolinium compounds against opportunistic fungal pathogens [J].
Boateng, Comfort A. ;
Zhu, Xue Y. ;
Jacob, Melissa R. ;
Khan, Shabana I. ;
Walker, Larry A. ;
Ablordeppey, Seth Y. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (05) :1789-1797
[5]   Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals [J].
Byrnes, Edmond J., III ;
Bartlett, Karen H. ;
Perfect, John R. ;
Heitman, Joseph .
MICROBES AND INFECTION, 2011, 13 (11) :895-907
[6]   Cryptococcus gattii: a resurgent fungal pathogen [J].
Chaturvedi, Vishnu ;
Chaturvedi, Sudha .
TRENDS IN MICROBIOLOGY, 2011, 19 (11) :564-571
[7]   Designing better drugs: predicting cytochrome P450 metabolism [J].
de Groot, Marcel J. .
DRUG DISCOVERY TODAY, 2006, 11 (13-14) :601-606
[8]   OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation [J].
Eastman, Peter ;
Friedrichs, Mark S. ;
Chodera, John D. ;
Radmer, Randall J. ;
Bruns, Christopher M. ;
Ku, Joy P. ;
Beauchamp, Kyle A. ;
Lane, Thomas J. ;
Wang, Lee-Ping ;
Shukla, Diwakar ;
Tye, Tony ;
Houston, Mike ;
Stich, Timo ;
Klein, Christoph ;
Shirts, Michael R. ;
Pande, Vijay S. .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2013, 9 (01) :461-469
[9]  
Emami S, 2002, ARCH PHARM, V335, P318, DOI 10.1002/1521-4184(200209)335:7<318::AID-ARDP318>3.0.CO
[10]  
2-O